Bifidobacterium animalis subsp. lactis XLTG11 improves antibiotic-related diarrhea by alleviating inflammation, enhancing intestinal barrier function and regulating intestinal flora.
- 2022-06-08
- Clinical Trial
- Food & Function 13(11)
- Baofeng Xu
- Shengnan Liang
- Jiayi Zhao
- Xuetong Li
- Jiayao Guo
- Bowen Xin
- Bailiang Li
- G. Huo
- Weiwei Ma
- PubMed: 35616024
- DOI: 10.1039/d1fo04305f
- Low evidence
- Animal Study
- Clinical
Inhibited toll-like receptor 4 (TLR4)/activation of the nuclear factor-κB (NF-κB) signaling pathway, significantly increased the levels of anti-inflammatory cytokines and decreased levels of pro-inflammatory cytokines.
- Effect
- Beneficial
- Effect size
- Large
- Significant
- Yes